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CORRESPONDENCE

reported (or Feldene exceeds that reported to the System for benoxaprofen (Oraflex), a structurally unrelated nonsteroidal antiinflammatory agent that has been withdrawn from the market. The original package insert for Feldene does not list photosensitivity as an
adverse reaction associated with its use. Yet 29 of 36 reactions asso( iated with this drug were clinically ((insistent with photosensitivity
reactions, and 2 of the remaining 7 reports of reactions were highly
suggestive of exacerbation by exposure to sunlight. The 29 patients
who had photosensitive eruptions (lb men and 13 women) ranged
in age from 20 to 74 years; one patient (a man) was black. In 19 of
the 29 patients the eruption occurred within four days and after
llieii first sun exposure after the initiation of Feldene therapy. A
majority of the cases included vesicles or bullae in sun-exposed
Ninas. Pruritus was frequently associated with the eruption.
The prompt onset of the eruption in relation to initial treatment
and sun exposure suggests a pholotoxic rather than a pholoallcrgic
reai lion. I line patients who had used thiazide diuretics for extended-periods ol time experienced photosensitivity reactions after
feldene was added to their therapeutic regimens, suggesting possible additive or synergistic phOtOlOxie elicits of feldene and
thiazides.
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to it. In neither ease was peripheral serotonin measured before
treatment.
A seven-year-old boy had been diagnosed as autistic al the age of
five. I he child had a variety ofj.he features typical of autistic children and was enrolled in a special-education program. His pediatrician had given him fenfluramine. 10 nig four times a day,, During
one month of treatment'with this agent the child became progressively irritable and fearful. His activity level increased as his
appetite decreased. Sleep was also disrupted. He deteriorated behaviorallv. and his family discontinued the medication. At our
examination, performed two months after treatment had been
stopped, his serotonin levels were not elevated (152 ng per milliliter)."
An 1 1-year-old autistic bov had been started on fenfluramine (10
mg four times a day) by his father, who had read the preliminary'
report by Gellcr et al Serotonin levels were not determined before
treatment. Over several days of treatment the child became more
irritable and agitated. Fenfluramine was discontinued. The box's
activity level was markedly increased during the time of treatment,
and his father sought an evaluation. At oui examination, one month
alter treatment had been discontinued, the child had a serotonin
level of 2 I 2 ng per milliliter.
ROBER'I S. Si I-KN. M i )
Adverse reactions to fenfluramine have been noted previously.
Huston, MA 0221 5
Beth Israel Hospital
In one double-blind investigation the elluacv of this agent as an
appetite suppressant was evaluated; both patients and phvsuians
were able lo identify the a< live agent Correctly in over 70 pel cent of
flic above letter was referred 10 Phzei Laboratories, manufacturCases largely on the basis ol side eHect.1
ers ol feldene, who oiler the lollow nig reply:
There is no rationale lot the use "I fenfluramine in autistic chilI a Ike I'.dilo!: Although Dr. Stern correctly notes thai the original dren who do not have elevated levels of serotonin furthermore, its
efficacy m this population remains to be clearly established. Physifeldene (piroxicam) package insert did not list photosensitivity recians should lie aware ol possible adverse effects ol this agent in
actions, thev were added in August 1982, three months before we
autistic Children and its investigational nature
received a communication from him. We made this change vOiunl Miily because we had received reports of such reactions (including
FRI i) K. VUI.KMAR. M D
cases bom Dr. .Stein) alter feldene was introduced, even though we
KIIKS I'M I . Pn I)
had iifil seen them in more than 1000 patients studied in our con
DoNM „ J Coins, M I)
trolled clinical trial*. We believe thai our current labeling, which
I l i w i ii A SIIAVWIT/, M I)
stales that these read ions occur m fewer (ban 1 per cent of patient!,
Vale I. niverxuv
is supported by tins experience.
New Haven, CT065IO
Child Sludv CcBfCI
Some government agencies, such as the Cou'imittce on Safety of
I Gellci F. RitvoBR, freeman HJ. Yuwiler A. Preliminary observations or. the
.Medicines m the United Kingdom and the Swedish Regulator)
effect of fenfluramine on blood serotonin and symptoms in throe autistic
Authority, routinely report information on advene reactions. Data
boyi N l-.ngl I Med l<«2; 307:163 9
bom llnse agencies suggcW that the incidence of phOtOICtUtlivil)
? Hartley HO. Stahl SM. Frccdman DX Hyperserotoncnna and amine metaboreactions with Feldene is probably on the same order ol magnitude
lite* in autistic and retarded children Aich (ien I'svxhiatrv 1977; 341521-J)
as (In incidence with olhei marketed nonsteroidal antiinflammatory
3 Vclin J(.', Temple AH Fenfluramine p«i*9*»lng I I'ediait lx»75. 87:1 I"
dings, including ibupiolni, mdomriharui, and .naproxen
4 Brown*ll KD, Stunkard AJ The ikmbteblind in danger untoward suns,
Ph/ri has recently reviewed side efleCti in over 70,000 patients
qtieines ol informed sonvrw Am I ISvyhiativ |U>C. 1 W |4H7 W
mound the win Id wl)0 were Heated will I'rldriit\xix well as m COftl
paialiw Studies with mdi anel hai in and napioxrii I >r'i mat, llogK
( IMFFIDIM, WD I'()| Y .Vivos I I IS
icai lions of anv kind o'ciuicd m about I to 3 per cent ol palicnts
and had a sunilai u>< idence with each ol the drugs.
To ihf I'.fiuoi Watson et al recently reported a case of poiyniyosi
Finally, it Shook) be itoted dial benoxnpijulcu was witlnbawii
tis induced by cimciidinc, a drug with a possible role as an immunefrom iltc market because ol hepatic and rsrtal toxicity, not because
modulator ( |an 20 issue) ! Sun e Novernbei 1982, WC have had the
ol photosensitivity, as implied ill Di Nteni't lillfi
uppottunil v lo lollow (lie patieul described hi then report and wish
lo prov iile lollow up data thai .o gur ac.i mst I he i "!<- ol < nun icbue in
KIM,IH S/M.MS. M I )
inducing polymyositis in t|\is patient.
I'fr/ei I .abot atoi irx
New York, NY Kiui 1
Although ci | net nil ne had been dis, oniinued m |anu.u \ I '*H'.' ihr
patient had active myositis when first seen },>• us fo January IUH-,
while taking prednisone (60 fflfi pet day) and njen aptopui me (SO
IRRI I AHII.I I V IN AU I LSI IC CHILDREN I HI,A I I-1*>
ma tliife tiinex a day), he had a severe e,xacerbatii>n ol myosins
Wl I II I FNI FCRAMINI.
ih profound weakness and elevation ol
kinai
.'K'l.OI Nl
Tu III' tidiloi A icpi'M In (teller et al, presented pit'hnnn.ii \
II pet hlei He denied uxinji i unci aluir oi ,,|i ohol Sun < iheu his
results siiui/esinig j|ie possible iiselulness Of (enfluiamine (a subslimyositis has irmaiueil BCttvt despite lie.ument with hitdi ,|.
luted pliruv let h\ lariunr vs it Ir I \ used as all ap|»elile tinppi rssatil I m piednisoiir and methotrexate
lite it i ai men I of infantile autism (July 15, I 982, issue) I lie i a ton
It is appareni thai l '< months alter diseoniinuaiiofl oi, irrn?lidinft,
ale ("i the use Of tljll agent rGstl on ill ability to lowei peripheial
this [latietu lontimiex to have progressivt polymyositis t*hl
blond levels ol seioioniii and on die olnri v alion dial a <uibslanl ial
'hatplv wnil |ue\lonsK reported eases of drug induced polv
iniflOriiy of^HUlillit prtx-onx have elevated peripheral hlOotl KTQ
myositis, in which remission of diseast was oljuerved WK>H aAet
loiuii levelfC I he report emphasized the prehminaiv tiatute of the
ilisi onimiiation of the thug Kot example, in all previous)) rtSK»rted
result* in a small sgiuple of three vouug aulistii bOVI With elcvaled
, ,oi • of peine illamnti axsoi iftted (Vols mvosius rerllisStl HI ot I too kl ''
i loioihii level* We have seen two our! m wltit li autistic t hildren
impiovement in hoil, ihtu.al and labm <
. lot w teBinies ol rnvositiwrit In Iliad vx 11! i I Ins agent ,oid appealed to have advene icai lioiu o,, in ied within six months o( stopping the drug
In no cww

